BridGene Biosciences
PrivateLast Round
Series B
Extension
Oct 16, 2025
Total Funding Raised
$79.02M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
BridGene Biosciences is a biotechnology company that develops therapeutics for traditionally untreatable targets by leveraging advanced technologies such as covalent chemistry, chemical proteomics, and quantitative mass spectrometry.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BridGene Biosciences Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
BridGene Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Oct 16, 2025 | ||||
| Series B | Jul 27, 2022 | ||||
| Series A | May 5, 2021 | ||||
| Grant | Sep 18, 2020 | ||||
| Grant | Sep 15, 2018 |
BridGene Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DYEE Capital | Series B |
| National Cancer Institute | Grant |
| Kaitai Capital | Series A |
| NIH RADx | Grant |
| Junson Capital | Series B |
| Lapam Capital | Series B Extension, Series B |
| Grains Valley Venture Capital | Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 5, 2026
Nobel laureate Bruce A. Beutler, M.D. joins the board.
- Oct 23, 2025
Presenting three posters at the 2025 AACR-NCI-EORTC International Conference.
BridGene Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BridGene Biosciences's valuation, stock price, and market status.